Charles Barkley isn’t afraid to speak his mind. It’s one of the many reasons that after a Hall of Fame basketball career he’s one of the most popular sports analysts in the business. During an appearance on the Pat McAfee Show on Friday, the 11-time All-Star and current analyst for TNT dished on the LIV Golf and PGA Tour controversy and supported players who took the money to join the Greg Norman led series that is funded by Saudi Arabia’s Public Investment Fund. “I want all the LIV… Source link
Read More »For stocks, ‘good news’ is a relative term: Morning Brief
This article first appeared in the Morning Brief. Get the Morning Brief sent directly to your inbox every Monday to Friday by 6:30 a.m. ET. Subscribe Tuesday, March 22, 2022 Today’s newsletter is by Emily McCormick, a reporter for Yahoo Finance. Follow her on Twitter When it comes to sparking a move higher in stocks, news doesn’t necessarily have to go from bad to good, or from good to great. “Very bad” to “slightly less bad” can be enough. And that reasoning offers one explanation for… Source link
Read More »COVID vaccines and relative effectiveness: Yahoo News Explains
On Thursday, Johnson & Johnson submitted it’s COVID-19 vaccine for Emergency Use Authorization by the U.S. Food and Drug Administration. If greenlit by the Food and Drug Administration, it could be the nation’s third COVID vaccine producer, joining Pfizer and Moderna. Johnson & Johnson said last week that its one-dose vaccine has an overall 66% efficacy rate, not as high as Pfizer or Moderna’s two-dose vaccines with nearly 95% efficacy. Yahoo News Medical Contributor Dr. Kavita Patel… Source link
Read More »